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Attenuated auto-lysosomal system has been asso-
ciated with Alzheimer disease (AD), yet all underly-
ing molecular mechanisms leading to this impair-
ment are unknown. We show that the amino acid
sensing of mechanistic target of rapamycin com-
plex 1 (mTORC1) is dysregulated in cells deficient
in presenilin, a protein associated with AD. In
these cells, mTORC1 is constitutively tethered to
lysosomal membranes, unresponsive to starvation,
and inhibitory to TFEB-mediated clearance due
to a reduction in Sestrin2 expression. Normaliza-
tion of Sestrin2 levels through overexpression or
elevation of nuclear calcium rescued mTORC1 teth-
ering and initiated clearance. While CLEAR network
attenuation in vivo results in buildup of amyloid,
phospho-Tau, and neurodegeneration, presenilin-
knockout fibroblasts and iPSC-derived AD human
neurons fail to effectively initiate autophagy. These
results propose an altered mechanism for nutrient
sensing in presenilin deficiency and underline an
importance of clearance pathways in the onset
of AD.
INTRODUCTION
Alzheimer disease (AD) is the most common neurodegenerative
disorder of our time. Functional abnormalities of autophago-
somes and lysosomes have been identified as some of the early
pathological features in AD brains, preceding the hallmark de-
posits of amyloid and Tau tangles (Nixon and Yang, 2011).
Enlargement of endosomal compartments containing amyloid
precursor protein (APP) peptides (Takahashi et al., 2002), lyso-
somal deficits, and progressive accumulation of autophagic
vacuoles are widely observed in AD human samples and corre-
sponding mouse models (Cataldo et al., 1997; Nixon and Yang,
2011; Nixon et al., 2005). The link between AD and the lysosomal2166 Cell Reports 14, 2166–2179, March 8, 2016 ª2016 The Authorssystem is strengthened by observations that polymorphisms
in several cathepsin genes increase the risk for AD (Bhojak
et al., 2001; Papassotiropoulos et al., 1999) and deletions of
lysosomal protease inhibitors cystatin B/C largely ameliorate
symptoms in AD mouse models (Mi et al., 2007; Yang et al.,
2011, 2014).
Impaired auto-lysosomal system, along with the consequen-
tial disruption of molecular trafficking and cellular signaling
(Dobrowolski and De Robertis, 2011; Sorkin and von Zastrow,
2009; Taelman et al., 2010), is strongly linked to neurodegener-
ation (Komatsu et al., 2006; Lipinski et al., 2010; Nixon, 2013).
Efficient (macro)autophagy is required to remove aggregated
proteins and defective organelles, whose accumulation associ-
ates with a number of human diseases like AD, Parkinson
disease, and amyotropic lateral sclerosis (Nixon, 2013). Auto-
phagy is strictly dependent on lysosomal function that is driven
by the nutritional status of the cell. Specifically, amino acids are
sensed by lysosomes through a protein complex (vacuolar
ATPase, Ragulator complex, and the Rag heterodimers A/B
and C/D) that tethers the mechanistic target of Rapamycin
complex 1 (mTORC1) to their membranes (Laplante and Saba-
tini, 2012; Nnah et al., 2015). The small GTPase Rheb (Ras ho-
molog enriched in brain) activates mTORC1 on lysosomal
membranes if TSC1/2 (tuberous sclerosis 1/2 complex) is inac-
tivated by growth factor signaling (Inoki et al., 2003; Tee et al.,
2003). Thus, mTORC1 activity is regulated by amino acid levels
(as readily monitored by tethering of the complex to lysosomal
membranes) and cellular signaling. Activity of mTORC1 has a
direct effect on the biogenesis of lysosomes and autophago-
somes through TFEB (transcription factor EB). TFEB is regu-
lated by mTORC1 and positively regulates the activity of the
CLEAR (coordinated lysosomal expression and regulation)
gene network encoding for lysosomal and autophagosomal
genes (Sardiello et al., 2009; Settembre et al., 2012). Under
normal feeding conditions, active mTORC1 phosphorylates
TFEB allowing it to remain in the cytoplasm. When cells starve,
mTORC1 displaces from the lysosomal membranes, is no
longer active, and is unable to phosphorylate TFEB that then
translocates into the nucleus to directly bind to promoter ele-
ments containing the CLEAR sequence (Settembre et al.,
Figure 1. Mechanistic Target of Rapamycin Complex 1 (mTORC1) Is Deregulated in PS Deficiency, Attenuating the CLEAR Network Activity
(A) Expression of the mTORC1 components involved in its tethering and activation at the lysosomes are lower (RagB and RagC, 0.4 ± 0.1; RagD, 0.6 ± 0.1;
p = 0.05) in PSDKO cells, while levels of TFEB are higher. Bar graph represents quantitative analysis of protein levels assessed by immunoblot analyses.
(B) PSDKO cells fail to efficiently activate the CLEAR gene network. Luciferase assay on WT and PSDKO cells transfected with the 43CLEAR firefly luciferase
reporter that were deprived of leucine overnight is shown. Data represent fold induction. Leucine-deprived PSDKO cells show a significant reduction of CLEAR
reporter activity as compared to WT controls (WT 6.7 ± 0.1 versus PSDKO 1.2 ± 0.1; p = 0.01). This starvation response can be normalized by expressing
exogenous PS1 or PS2-FLAG in PSDKO cells (5.4 ± 0.2 or 5.2 ± 0.2, respectively). Expression of FLAG-tagged PS1 and PS2 proteins is shown in representative
immunoblot analyses; the order of samples is kept the same as in presented CLEAR luciferase assays.
(legend continued on next page)
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2012, 2013). This way, the mTORC1/TFEB pathway determines
the activity of the auto-lysosomal system and the number of
associated organelles. The mTOR kinase activity has been
recently described as another risk factor for AD (Yates et al.,
2013).
Altogether, these observations motivated us to study the
regulation of the lysosomal mTORC1 pathway in early-onset fa-
milial AD (FAD) cells. FAD is caused by mutations in presenilin
1, 2 (PS1, 2) or APP. Besides the well-described functions of
PS1, 2 in the g-secretase complex, non-proteolytic functions
of both proteins are currently discussed. In this line, PS1, 2
deficiency (absence of PS proteins or AD-associated mutation)
is capable of impairing cellular calcium homeostasis of
the endoplasmic reticulum (ER) and lysosomes (Coen et al.,
2012; Popugaeva and Bezprozvanny, 2013; Tu et al., 2006)
and its lysosomal function (Dobrowolski et al., 2012; Lee
et al., 2010; Neely et al., 2011). Importantly, both alterations
constitute pathogenic hallmarks of FAD with a possible inter-
relationship (McBrayer and Nixon, 2013; Peric and Annaert,
2015). Although some of the mechanisms behind the auto-lyso-
somal dysfunction are known, such as PS-mediated pH alter-
ations (Lee et al., 2010), it is very likely that additional factors
contribute to autophagy malfunction in AD. Here, we studied
lysosomal mTORC1 signaling in PS deficiency. We observed
an attenuation of the CLEAR network activity and dysregulation
of the regulatory transcription factor TFEB due to the inability of
mTORC1 to properly sense amino acid availability in cells lack-
ing PS proteins. The mTORC1 dysregulation was established
by low nuclear/cytoplasmic calcium and consequently low
Sestrin2 (Sesn2) levels, the increase of which normalized
mTORC1 dynamics on lysosomal membranes and rescued
CLEAR network activity. Attenuation of clearance in brain-spe-
cific TFEB knockout (KO) mice led to accumulation of total
b-amyloid (Ab), high Ab42/40 ratio, paired helical filament
(PHF) phospho-Tau (pTau), and neurodegeneration in hippo-
campal regions. In PS-deficient cells or induced pluripotent
stem cell (iPSC)-derived human AD neurons, constitutively
active mTORC1 failed to initiate autophagy.
Our results highlight the importance of PSs in the lysosomal
pathway, and these data reveal PSs’ unanticipated role in
mTORC1 amino acid-sensing and TFEB-mediated CLEAR
network activity, the attenuation of which contributes to the
onset of AD-like pathophysiology in vivo.(C) FAD-associated PS1 point mutations were unable to rescue CLEAR attenu
plasmids. Unlike in the WT PS1 and g-secretase loss-of-function mutants, exp
starvation (WT, 6.87 ± 0.76; M146L, 1.39 ± 0.22; p = 0.001; A246E, 1.69 ± 0.31; p
4.15 ± 0.99; p = 0.09; all p values state significance toWT controls as indicated wit
in representative immunoblot analyses; the order of samples is kept the same as
(D) Time course of lysosomal inhibition. WT and PSDKO cells were treated with
noblotting for p62 and LC3I/II. In PSDKO cells, LC3 and p62 protein levels rema
CQ treatment and show a similar trend of p62 (at 2-hr time point, 1 ± 0.2 versus 0.6
1 ± 0.2 versus 0.51 ± 0.1; at 8-hr time point, 5.5 ± 1.1 versus 2.0 ± 0.4) accumul
assessed by immunoblot analyses.
(E) mTORC1 activity represented in immunoblots for phsopho-P70S6K. While mT
versus lane 5, PSDKO, 1.8 ± 0.11) and amino acid starvation conditions (lane 4,
insensitive to leucine or glutamine withdrawal and constitutively active in PSDKO
represented as mean ± SEM. Bar graph represents quantitative analysis of prote
Data are represented as mean ± SEM. See also Figure S1.
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The CLEAR Network Is Attenuated in PS Deficiency
Defective autophagy induction and flux have been attributed to
the absence of PS1 protein. Conflicting reports have implicated
lysosomal pH in the autophagic defects of PS1-deficient cells
due to the faulty maturation of v-ATPase and homeostatic cal-
cium changes (Coen et al., 2012; Lee et al., 2010; Zhang et al.,
2012). In an effort to better understand the lysosomal mTORC1
function in PS-deficient cells, we began our studies using the
readily available PS 1, 2 double KO (PSDKO) mouse embryonic
fibroblasts (MEFs) (Wakabayashi et al., 2009), then expanded
our analyses to human FAD fibroblasts and iPSC-derived human
neurons. As mTORC1 has yet to be characterized in PS defi-
ciency, we decided to determine the expression levels of
proteins associated with the complex. All proteins belonging to
the Rag complex were lower in expression, with RagB being
the most significantly reduced (Figure 1A). Expression of
mTOR and overall levels of the mTORC1-associated activator
Rheb proteins also were significantly reduced in PSDKO cells.
In contrast, we found elevated levels of the mTORC1 inhibitor
TSC2 and b-catenin in PSDKO cells, confirming results pub-
lished by us and others (Dobrowolski et al., 2012; Kang et al.,
2002). Increased expression of TFEB and its phosphorylated
formwas constantly detected in PSDKO cells (Figure 1A). Impor-
tantly, a re-expression of PS1 and PS2 in PSDKO cells normal-
ized the levels of Rag B-D, b-catenin, and TFEB (Figure S1D).
Next we determined whether these mTORC1-related differ-
ences in PS-deficient cells would have an impact on CLEAR
gene network activity and autophagy induction. For this pur-
pose, we transiently transfected PSDKO cells with previously
published 43CLEAR-firefly luciferase reporter (Sardiello et al.,
2009) and appropriate constitutive Renilla-luciferase constructs.
In amino acid starvation experiments, we found strongly reduced
activation of the CLEAR reporter expression upon leucine depri-
vation in PS-deficient cells, which was normalized by overex-
pressing either PS1 or PS2 construct (Figure 1B), further under-
lining the redundancy of the two PS isoforms and the importance
of g-secretase-independent function of these proteins. Since PS
loss does not entirely represent disease conditions, we per-
formed a PS1KO rescue experiment in which PS1 wild-type
(WT) or AD-associated PS point mutations were overexpressed;
the PS1 M146L, A246E, and L392V mutations were unable toation. PS1-deficient cells were transfected with WT PS1 or FAD-linked PS1
ression of FAD-linked PS1 mutations failed to rescue CLEAR induction upon
= 0.005; L392V, 1.97 ± 0.37; p = 0.008; D257A, 4.03 ± 0.89; p = 0.08; D385A,
h brackets). Expression of FLAG-tagged PS1WT andmutant proteins is shown
in CLEAR luciferase assays.
Chloroquine (CQ) for the indicated time points and lysates assayed by immu-
ined constantly lower than in WT controls. Note that PSDKO cells respond to
3 ± 0.1; at 8-hr time point, 2.3 ± 0.3 versus 1.3 ± 0.2) and LC3 (at 2-hr time point,
ation as WT cells. Bar graph represents quantitative analysis of protein levels
ORC1 activity is attenuated in control cells under baseline (lane 1, WT, 1 ± 0.1
Glu-, Leu-deficient medium containing 10% dFBS, respectively), mTORC1 is
cells (lane 8, WT, 0.1 ± 0.002 versus PSDKO 1.47 ± 0.15; p = 0.001). Data are
in levels assessed by immunoblot analyses.
Figure 2. Defective Amino Acid Sensing of mTORC1 in PSDKO Cells Is Mediated by Excessive RagA Binding and Independent of TSC2
Localization
(A) mTOR remains localized to lysosomes upon nutrient deprivation in PSDKO cells. WT and PSDKO cells were starved in amino acid-deficient medium (HBSS)
for 1 hr. The localization of mTOR and LAMP2 was determined by immunostaining. Insets depict selected fields that were magnified.
(B) TSC2 localizes normally to lysosomes upon nutrient deprivation in PSDKO cells. WT and PSDKO cells were starved, as above. The localization of TSC2 and
LAMP2 was determined by immunostaining. Insets depict selected fields that were magnified.
(C) The excessive lysosomal mTOR tethering under amino acid starvation conditions in PSDKO cells (cell 1) can be reversed by expression of exogenous PS1-
FLAG (cell 2).
(legend continued on next page)
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rescue the observed CLEAR network attenuation. Notably, the
secretase loss-of-function mutations D257A and D385A showed
a tendency to rescue PS loss in these experiments (Figure 1C).
Treatment of cells with g-secretase inhibitors did not show
significant effects on CLEAR network activity (Figure S1C), indi-
cating that the observed CLEAR-associated phenotype is
possibly secretase independent.
Western blot and qPCR analyses of autophagy-associated
genes further confirmed the attenuation of the CLEAR network.
We found the low levels of LC3AB and p62 and the ability of
PSDKO cells to induce autophagy to be significantly lower in
our flux assays (Figures 1D and S1A). To further confirm these
analyses, we used iPSC-derived human neurons depleted of
PS1 (Figure S1B). Importantly, overexpression of exogenous
PS1-FLAG normalized the autophagy flux levels in these
isogenic cultures; in all other experiments, cells with low pas-
sage numbers were used. Furthermore, in microscopic auto-
phagy flux assays using eGFP-mRFP-LC3 (Kimura et al.,
2007), we found an attenuation of baseline autophagy as indi-
cated by a moderate buildup of yellow LC3 puncta in PSDKO
cells (Figure S1F).
To ascertain the activity of mTORC1 under amino acid starva-
tion conditions, we cultured PSDKO cells in leucine- deficient
RPMI media containing dialyzed fetal bovine serum (FBS), as
recently described for other KO MEF cell lines (Peng et al.,
2014). In PSDKO cells, mTORC1 activity was largely insensitive
to amino acid starvation, as determined in pP70 immunoblot
analyses (Figure 1E), whereas mTOR protein stability was
increased in pulse-chase assays (Figure S1E). These findings
motivated us to investigate the dynamics of mTOR upon amino
acid withdrawal in PS-deficient cells.
Amino Acid Sensing of mTORC1 Is Impaired While TSC2
Dynamics Remain Unchanged in PS Deficiency
Amino acid starvation diffuses the otherwise tethered mTORC1
from the lysosomal membranes to the cytoplasm, whereas the
inhibitory TSC2 re-localizes from the cytoplasm to the lysosomal
membranes to inhibit Rheb (Demetriades et al., 2014; Menon
et al., 2014; Sancak et al., 2010). Since the levels of the RagB
to RagD proteins are lower in PSDKO cells (Figure 1A), we exam-
ined whether mTOR dynamics are changed upon nutrient
deprivation in PSDKO cells. In WT cells, mTOR co-localized to
LAMP2-positive vesicles in nutrient-rich conditions (Figure 2A).
Upon 1 hr of amino acid withdrawal (Hank’s balanced salt solu-
tion [HBSS]), mTOR diffused into the cytoplasm. Once the auto-
phagy pathway is induced and amino acid levels increase as a
result of protein breakdown, mTOR tethers back to lysosomal
membranes in a RagA-dependent manner. In PSDKO cells,
LAMP2-positive vesicles were more dispersed throughout the
cytoplasm and larger than in WT cells. Under nutrient-/amino
acid-rich conditions, mTOR localizes to lysosomes (Figure 2A(D) Quantification of lysosomal mTOR or TSC2 localization presented in (A)–(C)
0.75 ± 0.2; p = 0.01; TSC2/LAMP2 co-localization in WT, 0.8 ± 0.05 versus PS
0.78 ± 0.2 versus PSDKO + PS1-FLAG, 0.18 ± 0.1; p = 0.01.
(E) Co-immunoprecipation analyses of endogenous mTOR and TSC2 proteins to
and Rheb in PSDKO cells, whereas TSC2 protein-binding dynamics were similar
All scale bars, 10 mm. Data are represented as mean ± SEM. See also Figure S2
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mTOR remained localized to lysosomes in amino acid starvation.
To further test the PS dependence of lysosomal mTOR tethering,
we overexpressed PS1-FLAG in PSDKO cells (Figure 2C). Under
amino acid starvation conditions, mTOR dispersed from lyso-
somes only in cells expressing exogenous PS1-FLAG (cell 2 in
Figure 2C and quantifications in Figure 2D). In co-immunoprecip-
itation analyses, we observed an excessive binding of endoge-
nous mTOR protein to HA-RagA under amino acid starvation
conditions specifically in PSDKO cells (Figure 2E, lanes 3 and
4), further indicating a defect in the RagA-mediated amino acid
sensing of these cells.
Since TSC2 has been described to be required for complete
release of mTORC1 from the lysosomes upon amino acid starva-
tion (Demetriades et al., 2014), we next investigated TSC2 dy-
namics in WT and PSDKO cells in the same starvation assays.
We hypothesized that TSC2 fails to be recruited to the lyso-
somes under nutrient deprivation in PSDKO cells and thus is un-
able to fully release mTOR from lysosomes. Similar experiments
as those shown in Figure 2A were conducted and assessed for
TSC2 localization with LAMP2. However, no differences in
TSC2 localization could be detected between PSDKO and WT
cells (Figure 2B and quantifications in Figure 2D). Amino acid
deprivation for 1 hr re-localized TSC2 to LAMP2 vesicles in
both WT and PSDKO cells. Longer nutrient deprivation (4 hr)
kept TSC2 on the LAMP2 vesicles in both cell types (Figure S2),
even though mTOR re-localized to LAMP2 vesicles under pro-
longed starvation. We also show that refeeding both WT and
PSDKO cells with complete media after a brief amino acid star-
vation was sufficient to disperse TSC2 back to the cytoplasm
(Figure S2B). Furthermore, dissociation of TSC2 from HA-Rheb
in fed conditions was comparable between both, WT and
PSDKO cells (Figure 2E, lanes 6 and 8). We conclude that the
response of TSC2 to starvation and its shuttling are unchanged,
while mTORC1 dynamics, and hence amino acid sensing
through the mTOR tethering RagA proteins, are highly deregu-
lated in PS deficiency.
Increasing Cellular Calcium Normalizes Sesn2 Levels
and Rescues CLEAR Activity and mTORC1 Sensing in
PS-Deficient Cells
PS proteins have been described to exist as weak calcium leak
channels or as regulatory proteins of ER-resident calcium chan-
nels (Tu et al., 2006). PS-deficient cells hold less calcium in the
cytoplasm (Tu et al., 2006). Therefore, we asked if calcium plays
a role in regulating the defective mTORC1 diffusion phenotype in
PSDKO cells. We used Calcium Ionophore (CaI, A23187) to in-
crease overall calcium levels in the cytoplasm and other cellular
compartments by loading calcium from the extracellular environ-
ment (Resendez et al., 1985). WT and PSDKO cells were pre-
treated with CaI for 4 hr and then amino acid deprived (1 hris shown. mTOR/LAMP2 co-localization in WT, 0.23 ± 0.06 versus PSDKO,
DKO, 0.7 ± 0.05; p = 0.1; mTOR/LAMP2 co-localization in PSDKO (control),
HA-RagA and HA-Rheb show a sustained binding of mTOR proteins to RagA
in both cell lines under starvation versus fed conditions.
.
Figure 3. Low Nuclear Calcium Levels Are Responsible for Low Sesn2 Levels and mTOR Dysregulation in PS-Deficient Cells
(A and B) iPSC-derived human neurons expressing GCaMP6s-NLS or GCaMP6s used to determine nuclear and cytosolic calcium levels. mCherry was used
to visualize neuronal projections, whichwere largely excludedwhenGCaMP6s-NLS vectors were used. Images show orthogonal maximal intensity projections of
x/y, x/z, and y/z perspectives. PS1M146L, PS1A246E, and PS1 siRNA-depleted mutant neurons show a significant reduction of cytosolic and more significant
reduction of nuclear calcium levels (for cytosolic calcium levels, PS1M146L 0.61 ± 0.07, PS1A246E 0.65 ± 0.06, siRNA PS1 0.71 ± 0.05; p = 0.05; for nuclear
calcium levels, PS1M146L 0.55 ± 0.06, PS1A246E 0.48 ± 0.07, siRNA PS1 0.52 ± 0.06; p = 0.01).
(C) Elevated cellular calcium increases the otherwise low Sesn2 levels in PSDKO cells. WT and PSDKO cells were treated with increasing concentrations
of Calcium Ionophore (CaI, 2–10 mM) overnight followed by analyses for pCREB and Sesn2 protein levels (baseline pCREB levels, WT 1 ± 0.14 versus PSDKO
0.47 ± 0.11; p = 0.01; pCREB after CaI, 10 mM, WT 1.7 ± 0.2 versus PSDKO 0.89 ± 0.3; p = 0.1; baseline Sesn2 levels, WT 1 ± 0.1 versus PSDKO 0.3 ± 0.1;
p = 0.01; Sesn2 after CaI, 10 mM, WT 1.3 ± 0.3 versus PSDKO 1.3 ± 0.2; p = 0.01).
(D) PS regulates Sesn2 transcription. Sesn2 transcript levels are low in PS KO cells and increase with expression of exogenous PS1WT-FLAG constructs, while
AD-associated PS mutations do not (PSDKO + PS1-FLAG, 0.92 ± 0.1 and PS1KO + PS1-FLAG, 0.91 ± 0.1 versus PS1M146L, 0.41 ± 0.1, A246E, 0.48 ± 0.2,
L392V, 0.6 ± 0.1; p = 0.01).
(E and F) Sesn2 expression is dependent on PS1, CREB, and CaMKIV. qPCR analyses in (E) show low Sesn2, LC3, and p62 mRNA levels when PS1, CREB, or
CaMKIV are depleted in human neuronal cultures (for Sesn2 levels, siRNA control 1 ± 0.1 versus siRNA PS1 0.37 ± 0.1, siRNACREB 0.2 ± 0.1, and siRNACaMKIV
(legend continued on next page)
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HBSS) to assay for mTOR dynamics under starvation. Increasing
cytoplasmic calcium dispersed mTOR from LAMP2-positive
vesicles under fed and amino acid starvation in both cell lines,
thus, rescuing the mTOR-tethering phenotype in PSDKO cells
(Figures S3A and S3B).
Total cytosolic and nuclear calcium concentrations were as-
certained in three control and three PS1-deficient (M146L-,
A246E-, and small interfering RNA (siRNA)-depleted) human
neuron lines using the genetically encoded GCaMP6s (Chen
et al., 2013) and GCaMP6s-NLS sensors (Hagenston and Bad-
ing, 2011). We found low cytosolic calcium levels in PS-deficient
human neurons (Figures 3A and 3B), and we confirmed the find-
ings of other groups in other cell lines (Tu et al., 2006). Further-
more, we found that nuclear GCaMP6s-NLS fluorescence,
hence nuclear calcium levels, was reduced in PS-deficient neu-
rons (Figures 3A, 3B, and S3D). To assess the effects of nuclear
calcium signaling in cells, we performed immunoblot analyses of
CaI-treated cells for 4 hr. CaI significantly elevated the levels of
pCREB (cAMP response element-binding protein) and Sesn2,
the recently describedmTORC1-associated protein (Chantranu-
pong et al., 2014; Peng et al., 2014), strongly in PSDKO cells and
to a lower extent in WT cells (Figure 3C). We confirmed the PS-
dependent Sesn2 expression in qPCR analyses (Figures 3D
and S3E) using PS1 and PS1,2 DKO MEFs. Levels of Sesn2
mRNA significantly decreased in both PS KO cell lines were
normalized with overexpression of PS1WT-FLAG, but they did
not change when FAD-associated PS1 mutations were ex-
pressed. In iPSC-derived human neurons depleted of PS1, Ses-
trin levels were lower similar to MEFs and could be rescued with
hPS1-FLAG overexpression (Figures 3E and 3F). Given our re-
sults indicating the involvement of nuclear calcium signaling in
PS deficiency, we tested whether Sesn2 is a CaMKIV and
CREB target gene. Indeed, Sesn2 expression was dependent
on CaMKIV and CREB expression and could not be rescued
by an overexpression of PS1-FLAG alone, indicating that PS
function on Sesn2 is upstream of the CaMKIV/pCREB signaling
(Figures 3E and 3F). In all experiments, Sesn2mRNA and protein
levels strongly correlated with the expression levels of the auto-
phagosomal marker LC3 and autophagosome cargo marker
p62. Furthermore, Sesn2 promoter activity was significantly
lower in PS1-depleted neurons and could be increased by Cal-
cium Ionophore in a CREB-dependent manner (Figure 3G).
To further confirm the role of Sesn2 in neuronal mTOR
signaling, we analyzed the binding of endogenous mTOR pro-
teins to HA-RagA in iPSC-derived human neurons (Figure S3F).
Under amino acid starvation conditions, binding of mTOR
to HA-RagA was strongly increased when PS1 or Sesn2 was0.2 ± 0.1; p = 0.001). Expression of exogenous PS1WT-FLAG rescues LC3, p62,
Immunoblot analyses in (F) show the expression of the samples on protein level; al
(G) Sesn2 promoter activity measured in Sesn2-luciferase reporter assays is sig
PS1siRNA, 0.2 ± 0.01; p = 0.04; left bracket) and can be normalized to control le
CREB-dependent manner.
(H) Overexpression of Sesn1,2,3 or Sesn2 alone rescues the attenuated CLEAR ind
17.3 ± 3.3; p = 0.001; left bracket).
(I) Overexpression of Sesn2-FLAG in PSDKO cells disperses the otherwise tethe
expressing cell is depicted as 2. mTOR diffusion is visible in single-channel images
p = 0.05). Data are represented as mean ± SEM.
All scale bars, 10 mm. Data are represented as mean ± SEM. See also Figure S3
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pression of Sesn2-FLAG decreased the mTOR-RagA binding in
both conditions and cell lines (lanes 7–10). These data indicate
the potential involvement of nuclear calcium signaling on Sestrin
expression and neuronal homeostasis (Bading, 2013).We further
asked whether increasing Sestrin levels would impact the
CLEAR gene network activity. Exogenous Sesn2 or Sesn1, 2,
and 3 were capable of increasing CLEAR luciferase reporter
levels (Figure 3H) and dispersing the otherwise tethered mTOR
from lysosomes in PSDKO cells (Figure 3I). Importantly, both
treatments, CaI and Sestrin overexpression, largely eliminated
the differences in CLEAR network activity between WT and
PSDKO cells.
TFEB-Driven Clearance Functions Are Impaired in
PS-Deficient Cells
TFEB regulates the CLEAR gene network and its activity was
described to be associated with health and human disease
(F€ullgrabe et al., 2014; Settembre et al., 2013). Since TFEB is
regulated by mTORC1, which we found to be deregulated in
PS deficiency, we asked whether attenuation of the CLEAR
gene network may be attributed to a deregulation of this tran-
scription factor. The first indication of a deregulated mTOR/
TFEB pathway was provided by the CLEAR reporter assays.
We observed that moderate expression of exogenous TFEB-
FLAG proteins in PSDKO cells failed to significantly induce
CLEAR activation, while expression of the same amount of
TFEB-FLAG strongly induced activity of the network in WT cells
(Figure 4A). We therefore analyzed the localization of endoge-
nous TFEB proteins in PS-deficient and control cells under fed
and leucine-deprived conditions. We observed that TFEB was
not properly re-localized into the nucleus in leucine-starved
PSDKO cells, whereas nuclear TFEB was readily observed in
starved WT cells (Figures 4B and 4C). No significant changes
to TFEB localization could be found in PSDKO cells starved
with leucine-deficient RPMI media (containing 10% dFBS).
These data further indicate a deregulation of mTORC1 activity
and phosphorylation of its protein substrates, like TFEB, in PS-
deficient cells. Hence, we next overexpressed Sesn2-FLAG to
analyze the effect of mTORC1 activity on TFEB dynamics. We
predicted that exogenous Sestrin expression would inhibit
mTORC1-mediated phosphorylation through mTOR detach-
ment from lysosomal membranes. In both WT and PSDKO lines,
overexpression of Sesn2-FLAG was sufficient to re-localize
endogenous TFEB into the nucleus (Figure 4E), probably due
to its inhibitory effect on mTOR-RagA binding (Figure S3F) and,
subsequently, its activity (assessed later on in our study).and Sesn2 levels only in PS1-depleted neurons (0.89 ± 0.1; p = 0.1 to control).
l used siRNA pool-depleted protein levels to at least 40% of their control levels.
nificantly attenuated in PS1-depleted human neurons (control, 1 ± 0.1 versus
vels (control, 4.32 ± 0.5 versus PS1siRNA, 3.3 ± 0.7; p = 0.1; left bracket) in a
uction in PSDKO cells in CLEAR-luciferase reporter assays (1.35 ± 0.15 versus
red mTORC1 to lysosomes. PSDKO cell is labeled with 1 and Sesn2-FLAG-
of cell 2 (PSDKO, 0.88 ± 0.3 versus PSDKO +Sesn2-FLAG, 0.26 ± 0.1; n = 200;
.
(legend on next page)
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Since elevation of cellular calcium or Sestrin level restored
amino acid sensing in PSDKO cells, we analyzed whether auto-
phagy-related TFEB target genes, LC3 and p62, are increased
with these treatments. We found that CaI increased transcript
levels of Sestrin, LC3, and p62. We furthermore found that
Sesn2 expression for itself was required for sufficient LC3 and
p62 transcription (Figure 4F). Treatment of PS-deficient (M146L
or siRNA PS1-depleted) human neurons with CaI increased the
number of LC3-GFP-positive vesicles (Figures 4G and 4H) and
functional autophagy, as assessed in flux assays (Figure 4I).
Interestingly, PS1-depleted neurons showed lower Histone H3
acetylation and Sesn2 and LC3 expression, while CaI was
capable of increasing the levels of these proteins and inducing
autophagy, as seen in increased LC3II levels after Chloroquine
(CQ) treatment. Altogether these data underline the importance
of the nuclear calcium and Sesn2 functions in autophagy.
Attenuation of Cellular Clearance Leads to AD-like
Phenotypes and Degeneration
To test whether the mechanism presented here is relevant to hu-
man AD, we next determined the activity of the CLEAR network
in human cells (fibroblasts and neurons) and the consequences
of CLEAR network attenuation in vivo. Human fibroblasts
(M146L, A246E, L392V, and G209V; Coriell Institute) as well as
iPSC-derived human AD neurons (PS1M146L and PS1A246E)
showed small but significant attenuation of CLEAR luciferase re-
porter activity under baseline (fed conditions), whereas starva-
tion conditions showed an obvious defect in the initiation of the
CLEAR network (Figures 5A and 5B). We found the expected
mTORC1 dynamics in control human fibroblasts: mTOR proteins
appeared diffusely localized in the cytoplasm and only a small
amount of mTOR seemed still bounded to the lysosomal mem-
brane under starvation conditions. In FAD cells, however, most
of the cellular mTOR was localized to the lysosomal compart-
ment even under starvation conditions (Figure S5D).
To assess the consequences of an attenuation of the CLEAR
gene network, we analyzed the conditional deletion of TFEB in
the mouse brain (Tcfeb flox/flox:Nestin-Cre). Transcripts iso-
lated from the whole-brain lysates showed a strong reductionFigure 4. TFEB-Driven Clearance Functions Are Impaired Due to Low
(A) Unlike in WT cells, moderate expression of exogenous TFEB-FLAG proteins
3.0 ± 0.5; p = 0.03; left bracket, all aa; 15.5 ± 1.8 versus 3.6 ± 0.6; p = 0.008; rig
(B) TFEB dynamics are impaired in PSDKO cells. Whereas TFEB localizes to the cy
TFEB, 10% ± 2.7% versus 89% ± 10.8%; p = 0.004), localization of TFEB does no
TFEB, 16% ± 4.6% versus 26% ± 5.9%; p = 0.1).
(C and D) Cytoplasmic nuclear fractionation analyses show impaired TFEB nuclea
versus 0.81-fold ± 0.11; p = 0.1).
(E) Sesn2-HA overexpression rescues the TFEB-FLAG nuclear re-localization in P
versus 85% ± 11.9% in PSDKO cells).
(F) Transcriptional efficiency of LC3 and p62 dependents on Sesn2 expression (S
(G) Quantification of LC3-GFP-positive vesicles in human neurons after CaI trea
4.4 ± 2.1, 12.5 ± 2.6, p = 0.06, respectively).
(H) The number of LC3-GFP vesicles increases in PS1M146L human neurons aft
(I) Immunoblot analyses including autophagy flux assays in PS1-depleted, CaI-tr
pleted cells after CQ treatment (LC3, control, 3.1 ± 0.2 versus LC3, si.PS1, 1.26 ± 0
while a treatment with CI equilibrated the LC3 and Sesn2 levels of both cell lines t
Sesn2, control, 1.4 ± 0.2 versus Sesn2, si.PS1, 1.1 ± 0.1; p = 0.1).
All scale bars, 10 mm. Data are represented as mean ± SEM. See also Figure S4
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gene expression: p62 and LC3 (Figure S5C). Specifically, the hip-
pocampal region of 2-month-old mice showed a significant in-
crease of total Ab and PHF pTau buildup in the absence of
TFEB (Figure 5C). Biochemical analyses of total Ab and Ab42/
40 indicated a trend for total Ab and a significant increase of
the Ab42/40 ratio in TFEB-deficient whole-brain lysates (Figures
S5A and S5B). While minimal levels of the apoptotic marker
cleaved caspase 3were found in control animals, TFEB-deficient
brains showed a significant increase of apoptotic cells with
punctuated neuronal tubulin (Tuj1), indicative of axonal degener-
ation (Figure 5D).
These results imply an important role of the mTOR/TFEB-
driven clearance pathways in neuronal homeostasis, and they
associate these pathways directly with the onset of neurodegen-
erative pathophysiology like that seen in AD.
DISCUSSION
AD is characterized by a complex pathophysiology involving the
buildup of two main neurotoxic protein aggregates composed of
Ab or hyperphosphorylated Tau. Abnormalities in the auto-lyso-
somal system are discussed as the early features preceding the
well-known hallmarks (Nixon and Yang, 2011). Defective auto-
lysosomal system can directly impact molecular trafficking,
cellular signaling, and clearance, leading to disease onset in
the aging brain. Early-onset FAD is caused by mutations in
APP or PS. PS deficiency has been associated with lysosomal
function through the maturation of vATPase complex (Lee
et al., 2010) or independent of such (Coen et al., 2012; Neely
et al., 2011; Zhang et al., 2012).
In the research presented here, we showed that the levels, ac-
tivity, and dynamics of the major cellular kinase mTORC1—as
well as its functions in autophagosomal pathways—are dysregu-
lated in PS deficiency due to its excessive tethering to lysosomal
membranes. We found the key transcription factor for lysosomal
biogenesis, TFEB, to be highly phosphorylated in PSDKO cells
(Figure 1A) and human AD neurons. High levels of p-TFEB corre-
lated with attenuated CLEAR gene network activity (Figures 1B,Sesn2 Levels in PS-Deficient Cells
in PSDKO cells fail to sufficiently induce CLEAR activation. (10.9 ± 1.7 versus
ht bracket, no leucine).
tosol during feeding and enters the nucleus upon starvation inWT cells (nuclear
t significantly change before or after leucine withdrawal in PSDKO cells (nuclear
r re-localization in PSDKO cells (PSDKO all aa versus no Leu, 0.87-fold ± 0.12
SDKO cells (nuclear TFEB in Sesn2-FLAG-positive cells, 78% ± 10.9% in WT
esn2, 0.17 ± 0.03; LC3, 0.22 ± 0.04; p62, 0.21 ± 0.03; p = 0.01, respectively).
tment (Control, 6.8 ± 1.5, 14.1 ± 2.8; p = 0.05, 0.01, respectively; PS1M146L,
er CaI treatment (see white arrows).
eated human neurons show a reduction of LC3II and Sesn2 levels in PS1-de-
.2; p = 0.01; Sesn2, control, 1.1 ± 0.1 versus Sesn2, si.PS1, 0.4 ± 0.1; p = 0.01),
o each other (CI, LC3, control, 3.4 ± 0.48 versus LC3, si.PS1, 2.7 ± 0.3; p = 0.1;
.
(legend on next page)
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1C, 5A, and 5B) and reduced expression levels and, conse-
quently, function of the autophagosomal markers LC3 and p62
(Figures 1D, S1B, 3F, 4I, 6D, and 6E). Using exogenous, fluores-
cent LC3 biosensors, autophagy flux seemed moderately atten-
uated (Figure S1F); however, we would like to note that LC3 is a
target gene of TFEB whose activity is attenuated in PS-deficient
cells. Overexpression of exogenous LC3 in these cells likely
changes the autophagic phenotype of PS-deficient cells. We hy-
pothesized that the attenuated CLEAR gene network activity ex-
plains the lysosomal and autophagosomal inhibition found in PS
deficiency and early-onset FAD. All tested PS mutations associ-
ated with AD (but not g-secretase) showed a significant reduc-
tion of CLEAR gene network activity to starvation cues (Figures
1B, 1C, 5A, and 5B). These data seemingly disagree with a study
published by Zhang et al. (2012) stating increased lysosomal
biogenesis in PSDKO brains, itself objecting to studies showing
that increased TFEB-mediated clearance decreases pTau and
amyloid levels in AD mouse models (Polito et al., 2014; Xiao
et al., 2014), not contributing to their buildup. The reason for
these discrepancies are unknown; however, they could be due
to the use of whole-cell lysates and contamination through other,
non-neuronal cells.
Lysosomal localization ofmTORC1 is crucial for its activity and
is determined by the availability of amino acids (Sancak et al.,
2010). Localization of the Rheb inhibitors TSC1/2 determines
the activity of the complex and, thus, the phosphorylation state
of its protein substrates. We therefore closely monitored the dy-
namics of mTOR and TSC2 as well as mTORC1 activity in PS-
deficient cells. Depriving control cells of amino acids largely in-
hibited mTORC1 activity in controls, while PS-deficient cells,
MEFs, and human neurons maintained an active kinase complex
through a strong binding of mTOR to RagA (Figures 1E, 2E, and
S3F). The strong binding of mTOR to RagA correlates with its
constitutive tethering to lysosomal membranes (Figure 2A),
whereas TSC2 re-localized from the cytoplasm to the lysosomal
compartment in fed or amino acid-starved conditions, respec-
tively. These readily reproducible findings indicate that the amino
acid-sensing pathways in PS-deficient cells are largely dysregu-
lated and that TSC2 can tether to the lysosomal membranes
without displacing mTORC1. Since both proteins, mTOR and
TSC2, localize to the lysosomal compartment under starvation
conditions in PS-deficient cells (Figure S2A), our data support
the model proposed by Menon et al. (2014) in which TSC2
tethers to lysosomes via Rheb while mTORC1 remains boundFigure 5. Cellular Clearance Is Attenuated in AD Cells and Leads to AD
(A) iPSC-derived human neurons were used for CLEAR network reporter assay
efficiently express the CLEAR luciferase reporter under leucine starvation conditio
29.4 ± 2.2; p = 0.01).
(B) Defective activation of the CLEAR network activity upon leucine withdrawal in
control cell lines (M146L, A246E, L392V, and G209V, 1.7 ± 0.3, 1.6 ± 0.4, 1.5 ± 0.6
and 7.1 ± 1.0; p = 0.001).
(C) Attenuation of the CLEAR network in vivo: Tcfeb fl/fl:Nestin-Cre mouse brains
(77.2% ± 16.9%, p = 0.001 or 38.4% ± 9.3%, p = 0.003, respectively). Images sh
(D) An accumulation of the apoptotic marker cleaved caspase 3 and an irregular s
fl/fl:Nestin-Cre mutant mice were detected (21.8% ± 6.1%, p = 0.005 and 32.1%
projections of x/y, x/z, and y/z perspectives.
All scale bars, 20 mm. Data are represented as mean ± SEM. See also Figure S5
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et al., 2008, 2010).
We found that low Sesn2 levels are responsible for the exces-
sive mTORC1 tethering in PS-deficient cells (MEFs and iPSC-
derived human neurons) and that the reduction of Sesn2 expres-
sion is a consequence of the low nuclear calcium and CaMKIV/
pCREB signaling in PS deficiency (Figures 3A–3F and 4I).
Sesn2 has been described to be regulated by nuclear calcium
(Bading, 2013; Zhang et al., 2009) and to act as negative regu-
lator of mTORC1 by indirectly or directly regulating RagA func-
tion (Chantranupong et al., 2014; Peng et al., 2014), largely ex-
plaining our data showing excessive binding of mTOR to RagA
in PS deficiency (Figures 2E and S3F). Overexpression of
Sesn2 rescued CLEAR network activity and mTOR dynamics in
PSDKO cells (Figures 3H and 3I) and its binding to HA-RagA (Fig-
ure S3F) in PS-deficient human neurons. We conclude that the
mTORC1 phenotype we observed in PS deficiency can be
largely ascribed to low expression levels of the calcium-regu-
lated gene Sesn2 (see proposed model in Figure 6). The regula-
tion of TFEB through calcineurin (Medina et al., 2015) may pre-
sent a parallel way to regulate clearance in AD cells. Elevation
of endogenous Sesn2 levels resulted in increased autophagy in
PS-deficient cells. The effect of CaI on autophagic flux in PS-
deficient cells was most obvious in assays in which CQ was
used to inhibit lysosomal degradation of LC3-II (Figure 4I, lane
4 versus lane 8).
To understand the physiological consequence of an attenua-
tion of the TFEB-governed CLEAR network, we analyzed the tis-
sues of the brain-specific TFEB KO mice (Tcfeb fl/fl:Nestin-Cre).
Neuronal deletion of TFEB resulted in an accumulation of neuro-
toxic proteins like pTau and amyloid (Figures 5C and 5D). We
propose that the buildup of Ab42 peptides observed in our
biochemical studies (Figure S5A) is a consequence of an in-
crease of total Ab levels leading to possible changes in secretase
activities. Similar mechanisms have been proposed for trisomy
21-associated amyloidosis in which one additional copy of the
WT APP suffices to induce AD-like phenotypes (Masters et al.,
1985; Me´garbane´ et al., 2009). The observed axonal degenera-
tion and apoptotic cell death correlates with the buildup of
neurotoxic proteins. Interestingly, amounts of PHF pTau found
in TFEB KO animals showed a stronger association with
neuronal death than the increase of the endogenous, murine
(not aggregation-prone) Ab, implying a more direct role of pTau
in neurodegeneration.-like Phenotypes In Vivo
s. Neurons carrying the FAD mutations (PS1M146L and PS1A246E) failed to
ns (M146L, 11.2 ± 3.3, A246E, 12.3 ± 2.9 versus control I, 28.3 ± 6.7, control II,
FAD hFibroblasts carrying four different PS1 mutations and compared to four
, and 1.1 ± 0.5, respectively, versus control lines, 8.3 ± 1.2, 7.9 ± 1.2, 9.1 ± 1.4,
show an accumulation of Ab and PHF pTau (AT8) in the hippocampal regions
ow orthogonal maximal intensity projections of x/y, x/z, and y/z perspectives.
pread of the neuronal tubulin (Tuj1) in same hippocampal regions of the Tcfeb
± 8.1%, p = 0.004, respectively). Images show orthogonal maximal intensity
.
Figure 6. Model of PS Function in mTORC1/
TFEB Signaling through Regulation of Cal-
cium/Sestrin Levels
PSs as or part of a calcium channel on ER mem-
branes impact nuclear calcium levels that regulate
Sesn2 gene expression. Sufficient levels of Sesn2
proteins promote mTORC1 release from lyso-
somal membranes, this way inhibiting its activity.
Non-phosphorylated TFEB re-locates into the nu-
cleus to increase CLEAR network activity and
cellular clearance, antagonizing buildup of toxic
protein aggregates.One important physiological consequence for the attenuation
of the CLEAR gene network is the inhibition of autophagy, which
is tightly linked to cellular survival under stress conditions. Auto-
phagy inhibition has been directly associated to mTORC1 activ-
ity in TSC2-deficient cells (Menon et al., 2014).
Altogether, our data strongly suggest that PS deficiency con-
nects to lysosomal inhibition through a mechanism involving the
functional alteration of mTORC1 and the autophagosomal sys-
tem maintained by TFEB. We present here that the amino acid
sensing of mTORC1 is dysregulated in PS deficiency due to
low levels of the calcium-regulated gene Sesn2 (Figure 6). Atten-
uation of the clearance pathways leads to the onset of AD-like
phenotypes in mouse brains while PS-deficient cells fail to
induce autophagy, eventually exhausting their energy pools
and degenerating—a pathway that may likely be one possible
explanation for the onset of FAD.
EXPERIMENTAL PROCEDURES
Materials
All procedures involving mice were approved by the Institutional Animal Care
and Use Committee of the Baylor College of Medicine. All antibodies and re-
agents used in the presented experiments are described in the Supplemental
Experimental Procedures.
Immunostaining
Cells grown on coverslips were rinsed in PBS once and fixed in 4% parafor-
maldehyde. Cultures were then rinsed in PBS and blocked in 5% normal
goat serum, 0.5% BSA, and 0.5% TritonX100 in PBS for 45 min. Primary anti-Cell Reports 14, 2166–217body working solutions were made in blocking
buffer and incubated overnight at 4C. Cultures
were rinsed in PBS and placed in secondary anti-
bodies for 45min. The specimens were then rinsed
and mounted. Confocal images were obtained us-
ing a ZEISS spinning-disc microscope.
Cell Culture
WT and PS1/2 KOMEFs were provided by Bart de
Strooper (VIB Center for the Biology of Disease,
KU Leuven). MEFs were cultured in DMEM with
10% FBS. Human control and PS1M146L iPSCs
were obtained from Scott Noggle (The New York
Stem Cell Foundation Research Institute) and pre-
viously were characterized extensively (Sproul
et al., 2014). Human neuronal cultures were gener-
ated in the lab using the previously described dual-
Smad inhibition protocol (Chambers et al., 2009).
For the starvation assays, cells were plated at
low confluency (20,000 cells/24 wells) on cover-slips in 10% FBS-containing DMEM. The next day, fresh media were given
and the cells were allowed to stabilize for 2 hr, rinsed twice in HBSS (Gibco)
containing calcium and magnesium, and allowed to remain for the indicated
time points. For re-feeding experiments, cells were placed in HBSS for the indi-
cated time points and later replaced in nutrient-rich media (10% FBS/DMEM).
For leucine/glutamine deprivation experiments, cells were first plated and al-
lowed to stabilize in RPMI 1640 (without leucine and glutamine) containing
10% dFBS along with both leucine and glutamine. For leucine deprivation,
the media were then replaced with 10% dFBS in RPMI 1640 without leucine
alone for the indicated time points.
Statistics
The results are given as the mean ± SEM. Statistical analyses were performed
with Microsoft Excel using the two-tailed Student’s t test as appropriate.
Significant differences of means are indicated as *p% 0.05, **p % 0.01, and
***p% 0.005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.02.006.
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